Contraception with progestogens and progesterone during lactation
- PMID: 1835650
- DOI: 10.1016/0960-0760(91)90294-f
Contraception with progestogens and progesterone during lactation
Abstract
The growth and development of breastfed infants whose mothers used the contraceptive implants Norplant containing levonorgestrel and the injectable containing norethisterone enanthate were studied. Each group comprised of 120 women who initiated the use during the 5th to 7th week postpartum and were compared with a similar number of IUD using mothers. The breastfeeding performance did not differ between groups. The infants of the three groups performed similarly as regards their physical growth and health as well as the time of acquisition of the various milestones of psychomental development. A vaginal ring releasing 10 mg of the "natural" progesterone per 24 h was tested in breastfeeding mothers. The continuous use of the ring produced a serum level of progesterone around 4 ng/ml. This was effective in augmenting lactational infertility even through the later phases of breastfeeding when such an effect starts to wane off. The use of the ring proved to be acceptable and had no ill-effect on breastfeeding or infant growth or health. Using the natural progesterone as a contraceptive adds a new measure of safety, since the amount of the steroid secreted in the mother's milk will not be effectively absorbed from the infant's gut. These studies suggest the possibility of using two new methods for breastfeeding mothers; Norplant and the progesterone vaginal contraceptive ring. These can be initiated early postpartum, whenever this is considered needed.
PIP: Weight gain and psychomotor development of breastfed infants of Egyptian mothers using Norplant, Cu T-380A IUDs, norethisterone enanthate injectables (NET-EN), Depo Provera and a levonorgestrel minipill were compared in 2 trials. First, groups of 120 women using Norplant and NET-EN were compared to a control group using IUDs, beginning 5-7 weeks postpartum. There were no differences in infant weight gain, mid-arm circumference, triceps-skin-fold thickness, or timing of motor milestones. The mean growth curve of all 3 groups were close to that of the 50th percentile for Egyptian infants. While timing of initiation of supplements was similar in the 3 groups, complete weaning occurred first in the IUD group, second in the Norplant group, and last in the NET-EN users. A second trail compared progesterone implants injected with a trocar that resulted in a blood level of 3 ng/ml for 5 months, with Population Council vaginal rings releasing 10 progesterone/24 hours, and CuT-380A IUDs. Serum progesterone in the ring users averaged 5.2 ng/ml for the 1st 2 weeks, then leveled off at about 4 ng/ml for about 2 months, falling to about 3 ng/ml for the last 3 weeks of use. Each women used 4 rings per year. Evidence of ovulation by ultrasonic vaginal probe and assay of estradiol and progesterone was apparent in 25% of vaginal ring users, compared to 55.9% of controls in the 2nd 6 months postpartum. There was 1 pregnancy in a ring users. The continuation rates were 66.6% for rings and 85.5% for IUDs. The reasons for discontinuation in vaginal ring continuation were logistical problems and unfamiliarity.
Similar articles
-
The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.Contraception. 1998 Jun;57(6):371-9. doi: 10.1016/s0010-7824(98)00043-2. Contraception. 1998. PMID: 9693396 Clinical Trial.
-
Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.Contraception. 1997 Apr;55(4):225-32. doi: 10.1016/s0010-7824(97)00008-5. Contraception. 1997. PMID: 9179454 Clinical Trial.
-
Experience with NORPLANT in Egypt.Ann Med. 1993 Apr;25(2):167-9. doi: 10.3109/07853899309164162. Ann Med. 1993. PMID: 8489755 Review.
-
Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.Contraception. 1985 Dec;32(6):623-35. doi: 10.1016/s0010-7824(85)80006-8. Contraception. 1985. PMID: 3937665 Clinical Trial.
-
Long-acting hormonal contraceptives for women.J Steroid Biochem Mol Biol. 1991;40(4-6):697-704. doi: 10.1016/0960-0760(91)90293-e. J Steroid Biochem Mol Biol. 1991. PMID: 1958567 Review.
Cited by
-
Putative Mental, Physical, and Social Mechanisms of Hormonal Influences on Postpartum Sexuality.Curr Sex Health Rep. 2021 Dec;13(4):136-148. doi: 10.1007/s11930-021-00321-8. Epub 2021 Nov 25. Curr Sex Health Rep. 2021. PMID: 35707497 Free PMC article.
-
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.Contraception. 2022 Feb;106:16-33. doi: 10.1016/j.contraception.2021.10.001. Epub 2021 Oct 10. Contraception. 2022. PMID: 34644609 Free PMC article.
-
Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis.PLoS One. 2019 Nov 8;14(11):e0224898. doi: 10.1371/journal.pone.0224898. eCollection 2019. PLoS One. 2019. PMID: 31703094 Free PMC article.
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials